Faricimab by Roche is a strong competitor to Eylea.
wet age-related macular degeneration
Posted inNew Drugs, Regulatory
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration
Roche offered a convenient replacement for the traditional Lucentis.